Skip to content

Relating to the cost of prescription drugs.

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

OR SB 872 · Senate Bill · 2019 Regular Session

Stage
Session ended
Started in
Senate
Sponsors
37
Latest action
Jun 30, 2019

What it does

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total \tcost of] amount of money spent on patient assistance programs, \tand] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager. \tExcludes proprietary information from disclosure on department's website.] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. \tRequires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers.…

Read the full text

Where it stands

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

  1. Introduced (Current step)

    Introduced · Jun 30, 2019

  2. Committee (Needs attention)

    The session ended first

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money in Oregon.

Work with this bill

Relating to the cost of prescription drugs. | 52